Interpace Biosciences, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $22.4M | $47.0M | $7.1M |
| Jun 2017 | $17.4M | $53.7M | $14.3M |
| Sep 2017 | $14.0M | $50.4M | $11.7M |
| Dec 2017 | $13.7M | $36.6M | $15.2M |
| Mar 2018 | $13.3M | $53.1M | $12.6M |
| Jun 2018 | $12.8M | $51.4M | $10.1M |
| Sep 2018 | $13.8M | $49.8M | $8.0M |
| Dec 2018 | $15.7M | $31.1M | $6.1M |
| Mar 2019 | $18.6M | $54.4M | $9.1M |
| Jun 2019 | $19.5M | $50.3M | $4.2M |
| Sep 2019 | $37.9M | $74.7M | $2.4M |
| Dec 2019 | $29.8M | $51.5M | $2.3M |
| Mar 2020 | $25.1M | $60.8M | $13.4M |
| Jun 2020 | $30.2M | $60.6M | $15.1M |
| Sep 2020 | $26.0M | $50.7M | $5.3M |
| Dec 2020 | $28.2M | $45.7M | $2.8M |
| Mar 2021 | $30.2M | $43.9M | $2.8M |
| Jun 2021 | $32.4M | $43.2M | $3.8M |
| Sep 2021 | $32.4M | $40.3M | $3.2M |
| Dec 2021 | $34.3M | $38.4M | $2.7M |
| Mar 2022 | $36.2M | $38.4M | $2.9M |
| Jun 2022 | $36.9M | $35.5M | $1.9M |
| Sep 2022 | $30.4M | $15.3M | $6.3M |
| Dec 2022 | $32.5M | $16.0M | $4.8M |
| Mar 2023 | $26.8M | $16.0M | $5.6M |
| Jun 2023 | $26.2M | $16.1M | $5.1M |
| Sep 2023 | $30.4M | $14.3M | $5.0M |
| Dec 2023 | $22.1M | $13.1M | $3.5M |
| Mar 2024 | $20.4M | $12.1M | $2.8M |
| Jun 2024 | $18.7M | $13.0M | $500.0K |
| Sep 2024 | $18.0M | $14.0M | $1.4M |
| Dec 2024 | $17.0M | $14.8M | $1.5M |
| Mar 2025 | $15.1M | $14.5M | $1.2M |
| Jun 2025 | $13.5M | $12.3M | $502.0K |
| Sep 2025 | $12.3M | $12.0M | $1.4M |
| Nov 2025 | — | — | $2.1M |
| Dec 2025 | $11.5M | $33.8M | $2.5M |
| Mar 2026 | $10.3M | $33.4M | $2.6M |
| Jun 2026 | $11.3M | $34.5M | $2.7M |